Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Potent, long-acting ETA antagonist described by Zeneca

March 10, 1997

New PDE III/IV inhibitor described

March 10, 1997

Dual NEP/ECE inhibitor for heart failure

March 6, 1997

Potential agent for hypertension and CHF from Roche Bioscience

March 6, 1997

Zeneca presents potent and selective ETA receptor antagonist

March 6, 1997

Glaxo Wellcome evaluates melatonin agonist

March 6, 1997

Abbott describes AK inhibitor with anticonvulsant/neuroprotective effects

March 6, 1997

Selective, nonpeptide inhibitor of Ras farnesylation discovered by Schering-Plough

March 6, 1997

Orally active inhibitor of Ras farnesylation reported by Schering-Plough

March 5, 1997

Selective stromelysin-1 inhibitor described by Merck & Co.

March 5, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...